(Q37992879)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22411096%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Activation and regulation of interferon-β in immune responses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22411096%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22411096%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Wei-Xiang Sin

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22411096%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Peng Li

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22411096%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Keh-Chuang Chin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22411096%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22411096%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22411096%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22411096%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

1-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22411096%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

25-40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22411096%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12026-012-8293-7

25 January 2020

exact match

0 references

cites work

Virus interference. I. The interferon

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The interferons: 50 years after their discovery, there is much more to learn

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Purification and molecular characterization of human fibroblast interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Human leukocyte interferon: production, purification to homogeneity, and initial characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

NH2-terminal amino acid sequence of human fibroblast interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Interferons at age 50: past, current and future impact on biomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Long-term follow-up of the original interferon-beta1b trial in multiple sclerosis: design and lessons from a 16-year observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Enhancement of macrophage cytotoxicity against murine gliomas by interferon beta: increase in nitric oxide production in response to glioma-derived soluble factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I interferon response to extracellular bacteria in the airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The host type I interferon response to viral and bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Involvement of beta interferon in enhancing inducible nitric oxide synthase production and antimicrobial activity of Burkholderia pseudomallei-infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The yin and yang of type I interferon activity in bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Should we inhibit type I interferons in sepsis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I interferon production enhances susceptibility to Listeria monocytogenes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

IFN-beta increases listeriolysin O-induced membrane permeabilization and death of macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I interferon induction is detrimental during infection with the Whipple's disease bacterium, Tropheryma whipplei

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Mechanisms of pathogen entry through the endosomal compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Activation of innate immune antiviral responses by Nod2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Regulation of innate immune responses by DAI (DLM-1/ZBP1) and other DNA-sensing molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

IFNbeta responses induced by intracellular bacteria or cytosolic DNA in different human cells do not require ZBP1 (DLM-1/DAI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The HIN-200 family: more than interferon-inducible genes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

IFI16 is an innate immune sensor for intracellular DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Role of cell-to-cell variability in activating a positive feedback antiviral response in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Innate recognition of bacteria by a macrophage cytosolic surveillance pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The cytokine stew and innate resistance to L. monocytogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

21 January 2018

Viruses and interferons

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

IRF family proteins and type I interferon induction in dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Visualization of IFNbeta production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Regulation of effector and memory T-cell functions by type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Plasmacytoid dendritic cell-derived type I interferon is crucial for the adjuvant activity of Toll-like receptor 7 agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Second autologous transplant with cyclosporin/interferon alpha-induced graft versus host disease for patients who have failed first-line consolidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type 1 IFN mediates cross-talk between innate and adaptive immunity that abrogates transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Atypical chronic graft-versus-host disease following interferon therapy for chronic myeloid leukaemia relapsing after allogeneic BMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Humoral immunity due to long-lived plasma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Interferon alpha in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Interferon-alpha triggers B cell effector 1 (Be1) commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I interferons (alpha/beta) in immunity and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Structural biology of the Toll-like receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Triggering the interferon antiviral response through an IKK-related pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The receptor of the type I interferon family

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

21 January 2018

12 December 2020

JAK-STAT signaling: from interferons to cytokines

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I interferon signaling is required for activation of the inflammasome during Francisella infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Cryopyrin activates the inflammasome in response to toxins and ATP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Role of the caspase-1 inflammasome in Salmonella typhimurium pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The AIM2 inflammasome is critical for innate immunity to Francisella tularensis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I interferons in host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Mechanisms of the TRIF-induced interferon-stimulated response element and NF-kappaB activation and apoptosis pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

IRF7: activation, regulation, modification and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Chromatin structure and gene regulation in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

An Atomic Model of the Interferon-β Enhanceosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Virus Infection Induces NF-kappaB-dependent interchromosomal associations mediating monoallelic IFN-beta gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

IRF8 and IRF3 cooperatively regulate rapid interferon-β induction in human blood monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Poliovirus cell entry: common structural themes in viral cell entry pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Mycobacterium tuberculosis and the environment within the phagosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Nod-like receptors: cytosolic watchdogs for immunity against pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Host defense responses to infection by Mycobacterium tuberculosis. Induction of IRF-1 and a serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Recognition of cytosolic DNA activates an IRF3-dependent innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Pathogenesis of malaria and clinically similar conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Classical CD11c+ dendritic cells, not plasmacytoid dendritic cells, induce T cell responses to Plasmodium chabaudi malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I interferons in systemic autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Interferon regulatory factors in human lupus pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Negative regulation of interferon-β gene expression during acute and persistent virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Kaposi's sarcoma-associated herpesvirus immune modulation: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Mechanisms of autoinhibition of IRF-7 and a probable model for inactivation of IRF-7 by Kaposi's sarcoma-associated herpesvirus protein ORF45

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Inhibition of interferon regulatory factor 7 (IRF7)-mediated interferon signal transduction by the Kaposi's sarcoma-associated herpesvirus viral IRF homolog vIRF3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Conserved herpesviral kinase promotes viral persistence by inhibiting the IRF-3-mediated type I interferon response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Negative regulation of IRF7 activation by activating transcription factor 4 suggests a cross-regulation between the IFN responses and the cellular integrated stress responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Self protection from anti-viral responses--Ro52 promotes degradation of the transcription factor IRF7 downstream of the viral Toll-Like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Virus infection triggers SUMOylation of IRF3 and IRF7, leading to the negative regulation of type I interferon gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Acetylation of interferon regulatory factor-7 by p300/CREB-binding protein (CBP)-associated factor (PCAF) impairs its DNA binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Tripartite motif-containing protein 28 is a small ubiquitin-related modifier E3 ligase and negative regulator of IFN regulatory factor 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The transcription factor MafB antagonizes antiviral responses by blocking recruitment of coactivators to the transcription factor IRF3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

ARF-like protein 16 (ARL16) inhibits RIG-I by binding with its C-terminal domain in a GTP-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Absence of SHIP-1 results in constitutive phosphorylation of tank-binding kinase 1 and enhanced TLR3-dependent IFN-beta production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Absence of MyD88 results in enhanced TLR3-dependent phosphorylation of IRF3 and increased IFN-β and RANTES production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Expression, biological activities and mechanisms of action of A20 (TNFAIP3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

A20 is a negative regulator of IFN regulatory factor 3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Peroxisome proliferator-activated receptor gamma negatively regulates IFN-beta production in Toll-like receptor (TLR) 3- and TLR4-stimulated macrophages by preventing interferon regulatory factor 3 binding to the IFN-beta promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Cutting edge: autoantigen Ro52 is an interferon inducible E3 ligase that ubiquitinates IRF-8 and enhances cytokine expression in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Ubiquitin-dependent degradation of interferon regulatory factor-8 mediated by Cbl down-regulates interleukin-12 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Caspase-8-mediated cleavage inhibits IRF-3 protein by facilitating its proteasome-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

SUMO playing tag with ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

SUMO and ubiquitin paths converge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

SENP2 negatively regulates cellular antiviral response by deSUMOylating IRF3 and conditioning it for ubiquitination and degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Positive regulation of interferon regulatory factor 3 activation by Herc5 via ISG15 modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

S-glutathionylation of IRF3 regulates IRF3-CBP interaction and activation of the IFN beta pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Characterization of the human IRF-3 promoter and its regulation by the transcription factor E2F1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Direct repression of the human IRF-3 promoter by E2F1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Interferon regulatory factor 3-CL, an isoform of IRF3, antagonizes activity of IRF3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Functional characterization of interferon regulatory factor 3a (IRF-3a), an alternative splice isoform of IRF-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Inhibition of the IFN-β Response in Hepatocellular Carcinoma by Alternative Spliced Isoform of IFN Regulatory Factor-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Beyond the enhanceosome: cluster of novel κB sites downstream of the human IFN-β gene is essential for lipopolysaccharide-induced gene activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

MDA5 participates in the detection of paramyxovirus infection and is essential for the early activation of dendritic cells in response to Sendai Virus defective interfering particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

IRF-7 is the master regulator of type-I interferon-dependent immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I-IFNs control GVHD and GVL responses after transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Translational control of the innate immune response through IRF-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN- / on antigen cross-presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12026-012-8293-7

Type I IFNs enhance the terminal differentiation of dendritic cells

21 January 2018

1 reference

12 December 2020

Timing of IFN-β Exposure during Human Dendritic Cell Maturation and Naive Th Cell Stimulation Has Contrasting Effects on Th1 Subset Generation: A Role for IFN-β-Mediated Regulation of IL-12 Family Cytokines and IL-18 in Naive Th Cell Differentiation

1 reference

12 December 2020

Differential regulation of human blood dendritic cell subsets by IFNs

1 reference

12 December 2020

Inhibition of the IFN-beta response in hepatocellular carcinoma by alternative spliced isoform of IFN regulatory factor-3

1 reference

12 December 2020

M. tuberculosis and M. leprae Translocate from the Phagolysosome to the Cytosol in Myeloid Cells

1 reference

12 December 2020

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

1 reference

12 December 2020

Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection

1 reference

12 December 2020

ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation.

1 reference

12 December 2020

IFN-alpha/beta enhances BCR-dependent B cell responses

1 reference

12 December 2020

Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis

1 reference

12 December 2020

Inhibition of B cell receptor-mediated apoptosis by IFN.

1 reference

12 December 2020

Interferon-beta mediates opposing effects on interferon-gamma-dependent Interleukin-12 p70 secretion by human monocyte-derived dendritic cells

1 reference

12 December 2020

Regulation of human B cell responsiveness by interferon-alpha: interferon-alpha-mediated suppression of B cell function is reversed through direct interactions between monocytes and B cells

1 reference

12 December 2020

The transcriptional code of human IFN-beta gene expression

1 reference

12 December 2020

HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators

1 reference

12 December 2020

Beta interferon restricts the inflammatory potential of CD4+ cells through the boost of the Th2 phenotype, the inhibition of Th17 response and the prevalence of naturally occurring T regulatory cells

1 reference

12 December 2020

Interferon-alpha promotes survival of human primary B-lymphocytes via phosphatidylinositol 3-kinase

1 reference

12 December 2020

The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation

1 reference

12 December 2020

Roles of IFN-gamma and IFN-alpha in IL-12-induced T helper cell-1 development

1 reference

12 December 2020

10.1007/S12026-012-8293-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22411096%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference